Article
Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.
International journal of cancer - 15 Nov 2018
Xu Yinghui, Liu Hongliang, Liu Shun, Wang Yanru, Xie Jichun, Stinchcombe Thomas E, Su Li, Zhang Ruyang, Christiani David C, Li Wei, Wei Qingyi
Abstract excerpt
The toll-like receptor (TLR) signaling pathway plays an important role in the innate immune responses and antigen-specific acquired immunity. Aberrant activation of the TLR pathway has a significant impact on carcinogenesis or tumor progression. Therefore, we hypothesize that genetic variants in the TLR signaling pathway genes are associated with overall survival (OS) of patients with non-small cell lung cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
